Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MIP Diagnostics

MIP Diagnostics
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$2.09M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of molecular imprinted polymers (MIPS) and nanoMIPs/plastic antibodies technology designed to circumvent the drawbacks of traditional MIP manufacturing methods. The company's molecular imprinted polymers (MIPS) and nanoMIPs/plastic antibodies typically contain a single binding site for their target and are sufficiently small to be essentially soluble and can be fused to solid substrates, such as sensor surfaces, providing enterprises with ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Software
Primary Office
  • Fielding Johnson Building
  • University Road
  • Leicester LE1 7RH
  • England, United Kingdom

+44 0843 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MIP Diagnostics’s full profile, request a free trial.

MIP Diagnostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 08-May-2018 $2.09M 00.000 00.000 Completed Generating Revenue
4. Early Stage VC 28-Jun-2017 00000 00.000 00.000 Completed Generating Revenue
3. Early Stage VC 21-Oct-2016 00000 00000 00.000 Completed Startup
2. Early Stage VC 22-Dec-2015 $274K $274K 00.000 Completed Startup
1. Grant Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

MIP Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
A Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
B Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
B Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
A Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
A Ordinary 3,308 $0.013924 $76.58 $76.58 1x $76.58 9.54%
A Ordinary 3,000 $0.013924 $69.62 $69.62 1x $69.62 8.65%
To view this company’s complete Cap Table, request access »

MIP Diagnostics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Andrew Fisher Angel (individual) Minority 000 0000 000000 0
Calculus Capital PE/Buyout Minority 000 0000 000000 0
David Evans Angel (individual) Minority 000 0000 000000 0
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
Wellcome Trust Limited Partner 000 0000 000000 0

MIP Diagnostics Executive Team (3)

Name Title Board
Seat
Contact
Info
Adrian Kinkaid Chief Executive Officer & Board Member
Antonio Guerreiro Ph.D Director, Technology & Co-Founder
Sergey Piletsky Ph.D Co-Founder

MIP Diagnostics Board Members (3)

Name Representing Role Since Contact
Info
Adrian Kinkaid MIP Diagnostics Chief Executive Officer & Board Member 000 0000
Jim Reid MIP Diagnostics Chairman 000 0000
Sharon Spencer Ph.D MIP Diagnostics Board Member 000 0000